Jackson Lab hires new CFO



S. Catherine (Katy) Longley

S. Catherine (Katy) Longley

BAR HARBOR — The Jackson Laboratory announced April 21 that S. Catherine (Katy) Longley will join the nonprofit biomedical research institute as vice president and chief financial officer.

Beginning her new role as CFO in August, Longley will oversee all the lab’s financial activities.

“Katy is a seasoned executive with deep financial leadership experience,” said Chuck Hewett, executive vice president and chief operating officer at the lab. “Her expertise in audit and budgeting, debt issuance and financial strategy combined with her broad experience and responsibilities beyond finance will be critical assets to help grow The Jackson Laboratory to its next stage,”

For nearly 14 years, Longley has served as the senior vice president for finance and administration and treasurer at Bowdoin College, where she is the senior financial officer responsible for the institution’s strategic financial planning and budgeting, capital structure, operating budget and risk management and procurement.

She spent 12 years practicing law with Verrill & Dana, LLC, in Portland, including six as a partner. She also served for seven years as a commissioner in the administration of former Maine Governor Angus King, overseeing professional and financial regulation. Longley serves as a director of Camden National Corp.; is a member of the subscribers advisory board of United Educators, a reciprocal risk retention group in Bethesda, Md.; is a director of Maine Employers Mutual Insurance Company in Portland and serves on the board of Wheaton College in Norton, Mass. She holds a Bachelor of Arts degree from Bowdoin College as well as a Juris Doctor degree from Suffolk University Law School.

The Jackson Laboratory is an independent, nonprofit biomedical research institution based in Bar Harbor, with a National Cancer Institute-designated Cancer Center, a facility in Sacramento, Calif., and a new genomic medicine institute in Farmington, Conn. It employs 1,700 people, and its mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.